Status:

UNKNOWN

An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus

Lead Sponsor:

Buddhist Tzu Chi General Hospital

Collaborating Sponsors:

Pfizer

Conditions:

Systemic Lupus Erythematosus

Eligibility:

All Genders

16-80 years

Phase:

PHASE2

PHASE3

Brief Summary

The aim of this study is to to determine whether atorvastatin 40mg per day is effective in the treatment of SLE.

Detailed Description

Background: Statins are lipid-lower agents with pleiotropic effects. Beyond the traditional effect as inhibitors of 3-hydroxy-3methylglytaryl coenzyme A (HMG-CoA) reductase, it has anti-inflammatory a...

Eligibility Criteria

Inclusion

  • 16-80 years of age, fulfilling ACR criteria for the classification of SLE (no limit on disease duration)
  • Active disease status including (1) active nephritis with moderate proteinuria (between 1.0gm/day and 2.5gm/day) despite ongoing immunosuppressive therapy or (2) moderate active extra-renal component of the SLEDAI score in the range of 3 to 10. The SLE-DAI score should have been stable for at least two weeks prior to screening.
  • The type and number immunosuppressive agents were not changed in recent one months

Exclusion

  • inability to give informed consent;
  • myositis (CK\>3×normal value);
  • dialysis or serum creatinin\>2.5mg/dL;
  • abnormal liver function (ALT\>3×normal value);
  • pregnant or breastfeeding;
  • life-threatening illness that would interfere with ability to complete the study;
  • current drug or alcohol abuse
  • Already under statin therapy
  • Active SLE disease need added new immunosuppressive agent or increased current drug dosage for more than 50%.

Key Trial Info

Start Date :

March 1 2007

Trial Type :

INTERVENTIONAL

End Date :

March 1 2009

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00432354

Start Date

March 1 2007

End Date

March 1 2009

Last Update

March 20 2007

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Dalin Tzu Chi General Hospital

Chiayi City, Chia-yi, Taiwan, 622

2

Buddhist Dalin Tzu Chi General Hospital

Chiayi City, Taiwan, 622